“…Scaling up deep mutational scanning experiments to the scale of the genome is at present out of reach: bottlenecks include the precise, genome-wide introduction of individual mutations (mutagenesis efficiency and accuracy), sequencing costs and associating mutations at distant loci. The first is improving with advances in genome engineering, particularly from CRISPR-Cas9-based methods (Barbieri, Muir, Akhuetie-Oni, Yellman, & Isaacs, 2017;Haimovich, Muir, & Isaacs, 2015;Roy et al, 2018). The second is continuing to improve, following a long-term trend of decreasing costs (but see (Muir et al, 2016) for the alternative challenge of managing increasing amounts of data); and the third is becoming more feasible with emulsion-based generalized DNA assembly technologies that encapsulate single cells and enable distal DNA sites to be linked by sequencing (either by directly ligating mutated sites adjacent to each other (Haliburton, Shao, Deutschbauer, Arkin, & Abate, 2017;Zeitoun et al, 2015) or, more scalably, by ligating them to a cell-specific DNA barcode (Zeitoun, Pines, Grau, & Gill, 2017)) ( Figure 9).…”